Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/30354
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Sze Ting | - |
dc.contributor.author | Emmett, Louise M | - |
dc.contributor.author | Pattison, David A | - |
dc.contributor.author | Hofman, Michael S | - |
dc.contributor.author | Bailey, Dale L | - |
dc.contributor.author | Latter, Melissa J | - |
dc.contributor.author | Francis, Roslyn J | - |
dc.contributor.author | Scott, Andrew M | - |
dc.date | 2022 | - |
dc.date.accessioned | 2022-06-23T00:38:22Z | - |
dc.date.available | 2022-06-23T00:38:22Z | - |
dc.date.issued | 2022-06 | - |
dc.identifier.citation | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2022; 63(6): 819-822 | en |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/30354 | - |
dc.description.abstract | In nuclear medicine, theranostics is a burgeoning development that is rapidly being implemented worldwide. There is an increasing need to provide a multidisciplinary framework to the practice of theranostics, ensuring that patients receive this treatment safely and are secure in the knowledge that their health-care practitioners are adequately trained. Nuclear medicine experts in Australia have taken the initiative of producing a set of theranostic guidelines relevant to Australian medical practice. These guidelines encompass specialist qualifications, patient care, radiopharmaceutical production, radiation safety, and dosimetry. We propose adaptation of these guidelines by other countries, and we promote standards of practice leading to optimal clinical outcomes for patients receiving theranostic treatments. | en |
dc.language.iso | eng | |
dc.subject | general oncology | en |
dc.subject | guidelines | en |
dc.subject | molecular imaging | en |
dc.subject | radionuclide therapy | en |
dc.subject | theranostics | en |
dc.subject | training | en |
dc.title | The Importance of Training, Accreditation, and Guidelines for the Practice of Theranostics: The Australian Perspective. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | Journal of nuclear medicine : official publication, Society of Nuclear Medicine | en |
dc.identifier.affiliation | Olivia Newton-John Cancer Research Institute | en |
dc.identifier.affiliation | Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.. | en |
dc.identifier.affiliation | Department of Nuclear Medicine, Royal North Shore Hospital, Sydney, New South Wales, Australia.. | en |
dc.identifier.affiliation | Department of Nuclear Medicine and Specialised PET Services, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.. | en |
dc.identifier.affiliation | School of Medicine, University of Queensland, Brisbane, Queensland, Australia.. | en |
dc.identifier.affiliation | Department of Nuclear Medicine, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia | en |
dc.identifier.affiliation | Medical School, University of Western Australia, Perth, Western Australia, Australia.. | en |
dc.identifier.affiliation | Molecular Imaging and Therapy | en |
dc.identifier.affiliation | Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.. | en |
dc.identifier.affiliation | School of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia.. | en |
dc.identifier.affiliation | Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia.. | en |
dc.identifier.affiliation | St. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia.. | en |
dc.identifier.affiliation | Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.. | en |
dc.identifier.affiliation | Prostate Cancer Theranostics and Imaging Centre of Excellence, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.. | en |
dc.identifier.pubmeduri | https://pubmed.ncbi.nlm.nih.gov/35393349/ | en |
dc.identifier.doi | 10.2967/jnumed.122.263996 | en |
dc.type.content | Text | en |
dc.identifier.orcid | 0000-0001-8641-456X | en |
dc.identifier.orcid | 0000-0002-6656-295X | en |
dc.identifier.pubmedid | 35393349 | |
local.name.researcher | Lee, Sze Ting | |
item.grantfulltext | none | - |
item.fulltext | No Fulltext | - |
item.cerifentitytype | Publications | - |
item.languageiso639-1 | en | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.openairetype | Journal Article | - |
crisitem.author.dept | Molecular Imaging and Therapy | - |
crisitem.author.dept | Molecular Imaging and Therapy | - |
crisitem.author.dept | Olivia Newton-John Cancer Research Institute | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.